The Department of the Army Medical Command awarded a $1.5 million Project Grant to Liberating Technologies Inc. under the Military Medical Research and Development program (CFDA 12.420) to fund the development and clinical testing of an improved prosthesis control system utilizing voice recognition technology. The objective is to increase prosthesis use and functional outcomes for individuals with upper limb loss by providing an additional control modality. Shirley Ryan AbilityLab will receive a...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded The Cleveland Clinic Foundation a $1,448,174 Project Grant on June 1, 2024 to fund research on "INTUITIVE ULTRASOUND-BASED UPPER LIMB PROSTHETIC CONTROL AND FEEDBACK UTILIZING TARGETED REINNERVATION FOR NEUROMA PAIN." The research, conducted in collaboration with the University of California, Davis as a sub-awardee, aims to establish sonomyographic control parameters for patients with...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This $1,971,886 project grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research exploring the impact of microprocessor-controlled knees on prosthesis awareness and overall health. Virginia Commonwealth University is the primary awardee and will work with sub-awardees Hanger, Inc. and the University of Washington on this research from July 2021 through June 2025. The grant aims to transform military and...
This Project Grant award, valued at $3,999,779.00 and awarded on June 1, 2024, is funded by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The objective of this award is to develop a personalized, patient-centered prosthetic foot prescription and rehabilitation strategy to maximize mobility and satisfaction in veterans with lower limb loss. The prime awardee is Northwestern University, and the project...
The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...
This $1,097,466 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of portable integrated optic biosensors. These biosensors are intended to help identify early indications of potential loss of native tissue in the reconstruction of complex upper extremity amputations. The 2-year grant awarded to the Metis Foundation, a non-profit research organization, will fund the research, development, and...
The Department of the Army Medical Command awarded a $170,000 Project Grant to Sunnybrook Research Institute under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to expand knowledge and information delivery around improving upper extremity function after cervical spinal cord injury. Through this award, Sunnybrook Research Institute will deliver research that transforms healthcare for service members...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...
This federal Project Grant award of $1,991,326.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) aimed at suppressing barrier antimicrobial defenses in the context of trauma. The 3-year grant, with a performance period from September 30, 2024 to September 29, 2027, will enable Bidmc, a prominent academic medical center in...